Cardio Diagnostics Holdings CDIO
NASDAQ CDIO
$1.96 +0.04 (+2.08%)
At close: Oct 2, 2026 · 4:00 PM EDT

Cardio Diagnostics Holdings (CDIO) Return on Sales [ROS] (2022 - 2026)

Updated

Cardio Diagnostics Holdings (CDIO) recorded Return on Sales [ROS] of -27950.50% in Q2 2026, down 5492.99 percentage points from -22457.51% a year earlier but up 38647.89 percentage points from the prior quarter.

Analysis

Cardio Diagnostics Holdings (CDIO) Return on Sales [ROS] (2022 - 2026) Analysis & Trends

On a TTM basis, Cardio Diagnostics Holdings' Return on Sales [ROS] came in at -44690.68% as of Jun 30, 2026, down 12729.70 percentage points year-over-year; for FY2025, it came in at -43737.46%, down 19759.59 percentage points from FY2024.

  • Annual Return on Sales [ROS] has a four-year change of +25124.70 percentage points (FY2021 to FY2025).
  • Across earlier years, Return on Sales [ROS] came in at -23977.86% in FY2024 (+18462.56 pp), -42440.43% in FY2023 (+436343.89 pp), -478784.32% in FY2022 (-409922.16 pp) and -68862.15% in FY2021.
  • Quarterly Return on Sales [ROS] has ranged from -633581.58% in Q1 2023 to -14398.71% in Q3 2023 over the past five years.
  • On a year-over-year basis, Return on Sales [ROS] rose in 1 of the last eight quarters, with an average year-over-year change of -13727.53 percentage points.
  • Peak year-over-year performance for Return on Sales [ROS] in the last five years was a gain of 607476.31 percentage points in Q1 2024, against a drop of 147358.56 percentage points in Q1 2025 at the low end.
  • Per Business Quant, the preceding three quarters came in at -66598.40% (Q1 2026), -41159.55% (Q4 2025) and -59950.86% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Thermo Fisher Scientific 241.25 Bn 220.40 Bn 4.88 Bn 17.40%
2 Abbott Laboratories 167.33 Bn 138.41 Bn 7.27 Bn 13.44%
3 Danaher 148.83 Bn 132.65 Bn 3.61 Bn 17.99%
4 Intuitive Surgical 142.00 Bn 121.55 Bn 1.96 Bn 33.60%
5 Medtronic 110.70 Bn 76.57 Bn 6.34 Bn 18.08%
6 Stryker 104.72 Bn 90.84 Bn 4.50 Bn 25.18%
7 Boston Scientific 62.66 Bn 57.67 Bn 3.85 Bn 21.65%
8 Edwards Lifesciences 49.13 Bn 33.24 Bn 1.35 Bn 29.48%
9 Becton Dickinson 48.51 Bn 45.66 Bn 2.32 Bn 13.31%
10 Cardio Diagnostics Holdings 5.68 Mn -18.45 Mn - -27,950.50%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -27,950.50%
Mar 31, 2026 -66,598.40%
Dec 31, 2025 -41,159.55%
Sep 30, 2025 -59,950.86%
Jun 30, 2025 -22,457.51%
Mar 31, 2025 -173,463.83%
Dec 31, 2024 -33,608.20%
Sep 30, 2024 -21,412.87%
Jun 30, 2024 -16,295.55%
Mar 31, 2024 -26,105.27%
Dec 31, 2023 -29,039.51%
Sep 30, 2023 -14,398.71%
Jun 30, 2023 -148,008.17%
Mar 31, 2023 -633,581.58%
Dec 31, 2022 -250,321.79%
API Access

Cardio Diagnostics Holdings Return on Sales [ROS] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=CDIO&period=max&api_key=YOUR_API_KEY